Phreesia vs Sohar Health
Two Patient Access & Intake vendors, side by side. Facts from public sources; judgments are ours.
At a glance
Derived from public facts · a rough scale, not a ranking
| Phreesia | Sohar Health | |
|---|---|---|
| Pricing model | Subscription (per user or PMPM) · Custom quote, roughly $250+ monthly plus transaction fees | Not published · API usage pricing, quotes only |
| Speed to go live | Standard EHR-integrated intake rollout | API integration, customer live in 3 weeks |
| Automation model | Software platform · Intake, payments, and messaging | Data / network utility · Eligibility, benefits, and discovery API |
| Built for | Small practices, Mid-size groups, Enterprise systems | Mid-size groups, Enterprise systems |
| Security posture | SOC 2 Type II, HITRUST, PCI DSS, HIPAA | SOC 2 Type I, HIPAA |
| Company maturity | 21 yrs (est. 2005) | 3 yrs (est. 2023) |
| Financial backing | Public (NYSE: PHR) | $3.8M (seed, March 2025) · Seed |
| Named customers | 2 named | 5 named |
| Published results | Specific numbers public | No public numbers |
| Documented integrations | 5 listed | 3 listed |
| Third-party validation | None found | None found |
Bottom line
- Pick Phreesia if you want a proven, heavily certified intake and payments layer tied to your EHR and can live with custom quotes and module fees.
- Pick Sohar Health if you are a behavioral health or digital health platform with engineers and want real-time eligibility answers through an API in seconds.
Phreesia
Public company powering patient intake and payments
- Founded
- 2005
- HQ
- Wilmington, DE
- Stage
- Public (NYSE: PHR)
- Raised
- n/a
What it does
- Digital patient intake, registration, and consent management
- Insurance eligibility verification and card capture
- Patient payments, payment plans, and receivables financing (AccessOne)
- Automated appointment scheduling, reminders, and waitlist fill
- Patient surveys, screenings, and post-visit engagement
- Handles roughly 1 in 6 US patient visits
Where it's strong
- Massive proven scale: over 180 million patient visits enabled in 2025 and deep bidirectional integrations with every major EHR.
- Now GAAP profitable ($480.6M revenue, $2.3M net income in fiscal 2026), so vendor viability risk is low.
- The AccessOne acquisition adds patient payment plans and financing, making it a fuller patient-payments platform.
What buyers should weigh
- Part of its business model is pharma-sponsored patient messaging, which some organizations find uncomfortable in an intake tool.
- Pricing runs higher than point solutions, and smaller practices may pay for breadth they will not use.
- It covers intake, access, and payments but is not a denials or back-end RCM solution.
Named customers
HeartPlace · Summit Orthopedics
Integrations
Sohar Health
API-first AI eligibility verification and coverage discovery
- Founded
- 2023
- HQ
- New York, NY
- Stage
- Seed
- Raised
- $3.8M (seed, March 2025)
What it does
- Real-time eligibility checks, median response about 6 seconds
- AI-extracted benefit details, reported 96% accuracy
- Coverage discovery for patients without insurance details
- Bulk API supporting up to 1,000 verifications per call
- Configurable rulesets mapped to each payer and plan
Where it's strong
- Developer-first design makes it fast to embed verification directly in a digital intake flow.
- Strong fit for behavioral health, where benefit rules are messy and the customer list proves it.
- Small company means direct access to the founding team and quick iteration on payer edge cases.
What buyers should weigh
- Early stage with a $3.8M seed round, so weigh vendor longevity for anything mission critical.
- Customer base skews to behavioral health and telehealth; less proven in hospitals or complex specialty settings.
- Buyers without engineering resources will get less value from an API-first product.
Named customers
Talkiatry · Monument · LunaJoy · Finni Health · Legion Health
Integrations
Compare against the rest of Patient Access & Intake
Deciding between these two?
First Pass tracks Patient Access & Intake every week: funding, launches, and what changed since this page was written.